Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01535157
Title Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors South Plains Oncology Consortium
Indications

ovary epithelial cancer

peritoneal carcinoma

Therapies

Ketoconazole

Fenretinide

Age Groups: adult
Covered Countries USA


No variant requirements are available.